文献速递心境障碍

双相障碍死后脑组织炎症标志物的系统综述

Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review.
PubMed 文献 · Mol Psychiatry · 2019-06-27

该研究按PRISMA规范检索多个数据库至2019年3月的文献,系统综述双相障碍死后脑样本中炎症标志物证据。初筛1814篇中51篇测量了炎症标志物;部分研究提示存在炎症证据,但因多数研究未在同一脑样本中同时评估外周免疫细胞浸润、细胞因子水平与微胶质激活,尚不能断言双相障碍存在神经炎症。

要点

  • 部分死后脑研究提示双相障碍存在炎症证据,但证据不一致。
  • 15项微胶质标志物研究中8项未发现双相障碍效应。
  • 多数研究未在同一脑样本同时评估免疫细胞浸润、细胞因子与微胶质激活。

核心结论

  • 部分研究显示双相障碍死后脑样本存在炎症证据,但因多数研究未在同一脑样本中同时评估外周免疫细胞浸润、细胞因子水平与微胶质激活,尚不能断言双相障碍存在神经炎症。

研究设计与样本

  • 按PRISMA建议进行的系统综述,检索PubMed/MEDLINE、PsycINFO、EMBASE、LILACS、IBECS与Web of Science至2019年3月的同行评议文献,并用QUADAS-2工具评价纳入研究质量。
  • 初筛纳入1814篇文章,其中51篇测量了双相障碍死后脑样本的炎症标志物。

主要发现

  • 15项评估微胶质细胞标志物的研究中,8项未发现双相障碍对这些细胞有影响。
  • 51项研究中17项评估星形胶质细胞标志物:9项未发现双相障碍对星形胶质细胞有影响,8项发现减少,2项在不同脑区同时呈现增加与减少。
  • 研究间变异来源包括死后间隔、所研究脑区、诊断时年龄、是否接受治疗等。

临床怎么用

  • 解读死后脑炎症标志物证据时需考虑研究间异质性来源,如死后间隔、脑区、诊断年龄与治疗情况。
  • 不宜依据现有死后脑证据对双相障碍神经炎症作出确定性结论。

局限性

  • 多数研究未在同一死后脑样本中同时评估外周免疫细胞浸润、细胞因子水平与微胶质激活。
  • 研究间存在多种异质性来源,包括死后间隔、脑区、诊断时年龄与治疗等。
  • 需要未来分析校正这些潜在异质性来源并就炎症标志物达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bipolar disorder (BD) is a chronic affective disorder with extreme mood swings that include mania or hypomania and depression. Though the exact mechanism of BD is unknown, neuroinflammation is one of the numerous investigated etiopathophysiological causes of BD. This article presents a systematic review of the data regarding brain inflammation evaluating microglia, astrocytes, cytokines, chemokines, adhesion molecules, and other inflammatory markers in postmortem BD brain samples. This systematic review was performed according to PRISMA recommendations, and relevant studies were identified by searching the PubMed/MEDLINE, PsycINFO, EMBASE, LILACS, IBECS, and Web of Science databases for peer-reviewed journal articles published by March 2019. Quality of included studies appraised using the QUADAS-2 tool. Among the 1814 articles included in the primary screening, 51 articles measured inflammatory markers in postmortem BD brain samples. A number of studies have shown evidence of inflammation in BD postmortem brain samples. However, an absolute statement cannot be concluded whether neuroinflammation is present in BD due to the large number of studies did not evaluate the presence of infiltrating peripheral immune cells in the central nervous system (CNS) parenchyma, cytokines levels, and microglia activation in the same postmortem brain sample. For example, out of 15 studies that evaluated microglia cells markers, 8 studies found no effect of BD on these cells. Similarly, 17 out of 51 studies evaluating astrocytes markers, 9 studies did not find any effect of BD on astrocyte cells, whereas 8 studies found a decrease and 2 studies presented both increase and decrease in different brain regions. In addition, multiple factors account for the variability across the studies, including postmortem interval, brain area studied, age at diagnosis, undergoing treatment, and others. Future analyses should rectify these potential sources of heterogeneity and reach a consensus regarding the inflammatory markers in postmortem BD brain samples.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Giridharan VV, Sayana P, Pinjari OF, et al. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Mol Psychiatry. 2019. PMID: 31249382. doi:10.1038/s41380-019-0448-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。